New product intros (acetylsalicylic acid/omeprazole [new formulation], autologous skeletal myoblast sheets, brodalumab [new formulation], buprenorphine [new formulation], eteplirsen, ezetimibe [new indication], lesinurad sodium, opicapone, sofosbuvir/velpatasvir [new combination], sufentanil [new formulation])

2016 ◽  
Vol 52 (10) ◽  
pp. 585
Sign in / Sign up

Export Citation Format

Share Document